Zhuhai Trinomab Pharmaceutical Co., Ltd. (SHA:688806)
China flag China · Delayed Price · Currency is CNY
22.90
-1.16 (-4.82%)
At close: Nov 6, 2026

SHA:688806 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
1,329515.37559.41594.72758.35
Short-Term Investments
---30.81-
Cash & Short-Term Investments
1,329515.37559.41625.53758.35
Cash Growth
--7.87%-10.57%-17.51%-
Accounts Receivable
71.4683.14--16.31
Other Receivables
3.443.012.381.681.61
Receivables
74.9186.152.381.6817.92
Inventory
117.8995.1657.5325.0823.18
Other Current Assets
47.3841.959.6211.5432.03
Total Current Assets
1,569738.63628.96663.82831.47
Property, Plant & Equipment
188.56190.42219.13230.81215.27
Long-Term Investments
--12.2111-
Other Intangible Assets
5.415.362.863.53.61
Long-Term Deferred Charges
11.5815.3635.3664.3989.13
Other Long-Term Assets
83.9328.7234.7818.4111.97
Total Assets
1,859978.5933.3991.931,151

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Accounts Payable
24.1535.6593.2128.9335.37
Accrued Expenses
39.551.5329.2922.7117.88
Short-Term Debt
-67.0171.1928.0330.03
Current Portion of Long-Term Debt
224.28216.7164.32.9719.29
Current Portion of Leases
-11.4712.659.6214.01
Current Income Taxes Payable
1.52---0
Current Unearned Revenue
12.6758.77817.629.9
Other Current Liabilities
29.5311.656.736.737.85
Total Current Liabilities
331.65452.79285.38116.61134.33
Long-Term Debt
630.43363.74208.15111.5932.01
Long-Term Leases
20.236.9745.9851.4224.15
Long-Term Unearned Revenue
9.549.3410.74--
Total Liabilities
991.82862.84550.25279.63190.49

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Common Stock
460.55391.46371.2360148.62
Additional Paid-In Capital
2,1381,162859.5685.231,896
Retained Earnings
-1,751-1,449-847.7-332.93-1,083
Comprehensive Income & Other
-2.93-0.490.050-0.02
Total Common Equity
843.71103.66383.05712.3960.96
Minority Interest
23.3112.01---0
Shareholders' Equity
867.03115.66383.05712.3960.96
Total Liabilities & Equity
1,859978.5933.3991.931,151

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Total Debt
874.91695.91402.27203.64119.5
Net Cash (Debt)
454.27-180.53157.14421.9638.86
Net Cash Growth
---62.75%-33.96%-
Net Cash Per Share
1.12-0.470.431.343.99
Filing Date Shares Outstanding
444.36391.46371.2314.41159.95
Total Common Shares Outstanding
444.36391.46371.2314.41159.95
Working Capital
1,238285.84343.58547.21697.14
Book Value Per Share
1.900.261.032.276.01
Tangible Book Value
838.398.29380.18708.8957.36
Tangible Book Value Per Share
1.890.251.022.255.99
Machinery
-242.09236.55215.04205.79
Construction In Progress
-1.491.728.575.42